top
Please input keywords
OK
Database
News events
Contact us
EN
CN
JP
KR
About us
Introduction
History
Management team
Culture
Social Responsibility
Join us
Antibody Assets
Project Integrum
Antibody discovery platforms
Pipeline
Clinical pipeline
Preclinical pipeline
RenMice
RenMab
RenLite
RenNano
Animal Models
Pharmacology Service
Gene Editing
Collaborations
IR
Stock Information
Financial Reports
Listing Documents
Announcements & Notices
Corporate Governance
Investor Calendar
Email Alert
IR Contact
Home
News events
Downloads
Poster Downloads
Media Center
News
Events
Webinar
Publication
Downloads
Poster Downloads
Brochure
2023
SITC 2023: Fc-Competent Fully Human Anti-TIGIT Blocking Monoclonal Antibodies Demonstrated Potent Anti-Tumor Efficacy in Preclinical Models
2023
SITC 2023: Development of a Preclinical CD98HC Mouse Model for Therapeutic Studies
2023
SITC 2023: Generation and Validation of Humanized GARP/TGFB1 Mice for Testing Novel Anti-human GARP Antibodies
2023
SITC 2023: Humanized CD200/CD200R Mice as a Tool for Evaluating Novel Therapeutics
2023
SITC 2023: Humanized ICOS Mice as a Novel Tool for Predicting and Monitoring T-cell-mediated Immunotherapy Response
2023
SITC 2023: Humanized NKP46 Mouse Models for Testing Novel NK Cell-based Immunotherapies
2023
SITC 2023: Preclinical CD3-based Mouse Models for Evaluation of Bi-specific T-cell Engager Antibodies
2023
SITC 2023: A Novel B2m-deficient Immunodeficient Model Expressing Human IL15 for Preclinical Evaluation of T Cell and NK Cell-based Therapies
2023
ESMO2023: Phase I open-label, dose escalation and expansion study of YH003, an anti-CD40 agonist monoclonal antibody in combination with Toripalimab in patients (pts) with advanced solid tumours
1
2
3
4
5
6
…
14
GO
